Therapeutic potential of phosphodiesterase type 4 inhibition in chronic autoimmune demyelinating disease (Q73846717)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9357447 AND SRC:MED&resulttype=core&format=json

7 November 2019

title

Therapeutic potential of phosphodiesterase type 4 inhibition in chronic autoimmune demyelinating disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9357447 AND SRC:MED&resulttype=core&format=json

7 November 2019

main subject

demyelinating disease

1 reference

N Sommer

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9357447 AND SRC:MED&resulttype=core&format=json

7 November 2019

H F McFarland

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9357447 AND SRC:MED&resulttype=core&format=json

7 November 2019

L Quigley

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9357447 AND SRC:MED&resulttype=core&format=json

7 November 2019

B Cannella

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9357447 AND SRC:MED&resulttype=core&format=json

7 November 2019

D E Scott

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9357447 AND SRC:MED&resulttype=core&format=json

7 November 2019

P A Löschmann

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9357447 AND SRC:MED&resulttype=core&format=json

7 November 2019

M K Racke

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9357447 AND SRC:MED&resulttype=core&format=json

7 November 2019

publication date

1 October 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9357447 AND SRC:MED&resulttype=core&format=json

Journal of Neuroimmunology

7 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9357447 AND SRC:MED&resulttype=core&format=json

7 November 2019

volume

79

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9357447 AND SRC:MED&resulttype=core&format=json

7 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9357447 AND SRC:MED&resulttype=core&format=json

7 November 2019

page(s)

54-61

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9357447 AND SRC:MED&resulttype=core&format=json

T cell receptors in murine autoimmune diseases

7 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016/S0165-5728(97)00111-2

7 January 2021

Immunodetection and quantitation of the two forms of transforming growth factor-beta (TGF-beta 1 and TGF-beta 2) secreted by cells in culture

1 reference

https://api.crossref.org/works/10.1016/S0165-5728(97)00111-2

7 January 2021

Large scale preparation of myelin basic protein from central nervous tissue of several mammalian species

1 reference

https://api.crossref.org/works/10.1016/S0165-5728(97)00111-2

7 January 2021

Prevention of autoimmune demyelination in non-human primates by a cAMP-specific phosphodiesterase inhibitor

1 reference

https://api.crossref.org/works/10.1016/S0165-5728(97)00111-2

7 January 2021

Diversity of T cell receptor alpha and beta chain genes expressed by human T cells specific for similar myelin basic protein peptide/major histocompatibility complexes

1 reference

https://api.crossref.org/works/10.1016/S0165-5728(97)00111-2

7 January 2021

Monoclonal anti‐TNFα Antibody as a Probe of Pathogenesis and Therapy of Rheumatoid Disease

1 reference

https://api.crossref.org/works/10.1016/S0165-5728(97)00111-2

7 January 2021

Immunological aspects of demyelinating diseases

1 reference

https://api.crossref.org/works/10.1016/S0165-5728(97)00111-2

7 January 2021

Phosphatidylserine, a putative inhibitor of tumor necrosis factor, prevents autoimmune demyelination

1 reference

https://api.crossref.org/works/10.1016/S0165-5728(97)00111-2

7 January 2021

Characterization of cAMP-dependent inhibition of LPS-induced TNF alpha production by rolipram, a specific phosphodiesterase IV (PDE IV) inhibitor

1 reference

https://api.crossref.org/works/10.1016/S0165-5728(97)00111-2

7 January 2021

Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease

1 reference

https://api.crossref.org/works/10.1016/S0165-5728(97)00111-2

7 January 2021

Phosphodiesterase inhibitor pentoxifylline, a selective suppressor of T helper type 1- but not type 2-associated lymphokine production, prevents induction of experimental autoimmune encephalomyelitis in Lewis rats

1 reference

https://api.crossref.org/works/10.1016/S0165-5728(97)00111-2

7 January 2021

An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016/S0165-5728(97)00111-2

7 January 2021

The presence of interleukin 4 during in vitro priming determines the lymphokine-producing potential of CD4 T cells from T cell receptor transgenic mice

1 reference

https://api.crossref.org/works/10.1016/S0165-5728(97)00111-2

7 January 2021

Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro

1 reference

https://api.crossref.org/works/10.1016/S0165-5728(97)00111-2

7 January 2021

Prevention of chronic relapsing experimental autoimmune encephalomyelitis by soluble tumor necrosis factor receptor I

1 reference

https://api.crossref.org/works/10.1016/S0165-5728(97)00111-2

7 January 2021

The specific type IV phosphodiesterase inhibitor rolipram suppresses tumor necrosis factor-alpha production by human mononuclear cells

1 reference

https://api.crossref.org/works/10.1016/S0165-5728(97)00111-2

7 January 2021

Enhanced tumor necrosis factor suppression and cyclic adenosine monophosphate accumulation by combination of phosphodiesterase inhibitors and prostanoids

1 reference

https://api.crossref.org/works/10.1016/S0165-5728(97)00111-2

7 January 2021

The antidepressant rolipram suppresses cytokine production and prevents autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016/S0165-5728(97)00111-2

7 January 2021

Salbutamol up-regulates PDE4 activity and induces a heterologous desensitization of U937 cells to prostaglandin E2. Implications for the therapeutic use of beta-adrenoceptor agonists

1 reference

https://api.crossref.org/works/10.1016/S0165-5728(97)00111-2

7 January 2021

Heterogeneity of T-cell receptor alpha-chain complementarity-determining region 3 in myelin basic protein-specific T cells increases with severity of multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016/S0165-5728(97)00111-2

7 January 2021

The pathophysiology of tumor necrosis factors

1 reference

https://api.crossref.org/works/10.1016/S0165-5728(97)00111-2

7 January 2021

Rolipram, a novel antidepressant drug, reverses the hypothermia and hypokinesia of monoamine-depleted mice by an action beyond postsynaptic monoamine receptors

1 reference

https://api.crossref.org/works/10.1016/S0165-5728(97)00111-2

7 January 2021

Rise and Fall of Cyclic AMP Required for Onset of Lymphocyte DNA Synthesis

1 reference

https://api.crossref.org/works/10.1016/S0165-5728(97)00111-2

7 January 2021

https://api.crossref.org/works/10.1016/S0165-5728(97)00111-2

1 reference

7 January 2021

Results of a phase II study of the antidepressant effect of rolipram

1 reference

https://api.crossref.org/works/10.1016/S0165-5728(97)00111-2

7 January 2021

10.1016/S0165-5728(97)00111-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9357447 AND SRC:MED&resulttype=core&format=json

7 November 2019

1 reference